FDA Approves Gene Therapy for Retinal Dystrophy

Drug Industry Daily
A A
The FDA approved Spark Therapeutics’ novel gene therapy to treat an inherited form of vision loss — making it the first genetic therapy approved in the U.S. to target a disease caused by a specific gene’s mutations.

To View This Article:

Login

Subscribe To Drug Industry Daily